NF2 and cancer: Tumours are known regions of poor nutrient availability due to the metabolic activation inherent to cancer [66], alongside reduced perfusion of metabolites and serum-derived factors [67], therefore the ability to escape an anti-proliferative response to glucose/serum-factor starvation would confer an advantage to NF2-mutant tumour initiators.